Skip to main content
Journal of Clinical Medicine logoLink to Journal of Clinical Medicine
. 2026 Jun 9;15(12):4463. doi: 10.3390/jcm15124463

Synchronous Bilateral Carotid Body and Bilateral Vagal Paragangliomas: A Case Report and Literature Review

Nahar Alanezi 1,*, Yazeed Alofisan 2, Mohammed Dahman 3, Hassan Gado 2, Majid Althobaiti 4, Omar Tawfiq Abualnasr 5, Tariq Alanezi 6
Editor: Seamus O’Reilly
PMCID: PMC13302000  PMID: 42355631

Abstract

Background: Head and neck paragangliomas (HNPGLs) are rare neuroendocrine neoplasms that may be sporadic or hereditary and may occur as isolated, multifocal, or syndromic disease within the pheochromocytoma-paraganglioma spectrum. Synchronous bilateral carotid body tumors (CBTs) and bilateral vagal paragangliomas (VPGLs) are exceptional, particularly when biochemical activity and metastatic nodal involvement coexist. Case Presentation: We report a 33-year-old man with a 2-year history of enlarging bilateral neck masses, positive family history, and markedly elevated noradrenaline (6430 pg/mL; reference range <750 pg/mL). Initial CT angiography suggested bilateral CBTs, and Metaiodobenzylguanidine (MIBG) scintigraphy did not demonstrate abnormal adrenal or distant uptake. After alpha- and beta-blockade, staged surgery was performed. Right CBT excision demonstrated metastatic PGL, with two of four lymph nodes positive. Subsequent MRI and operative reassessment revealed synchronous bilateral CBTs and bilateral VPGLs. Left-sided surgery required partial debulking of a vagal-adherent mass to preserve nerve continuity; pathology confirmed PGL with Ki-67 index approximately 2% and left neck nodes were negative. Postoperatively, profound bradycardia required temporary then permanent pacing, together with bilateral vocal cord paralysis. During follow-up, swallowing and voice improved, the pacemaker was removed, and late imaging showed stable residual cervical disease without visceral metastasis on chest/abdominal CT. Conclusions: This case highlights the diagnostic and therapeutic complexity of multicentric, biochemically active HNPGLs and supports individualized multidisciplinary management, genetic counseling, biochemical surveillance, and long-term follow-up.

Keywords: head and neck paraganglioma, carotid body tumor, vagal paraganglioma, multicentric disease, catecholamines, complex vascular tumor, genetic testing

1. Introduction

Paragangliomas (PGLs) are rare, highly vascular neuroendocrine tumors arising from extra-adrenal paraganglia derived from the embryonic neural crest [1]. They belong to the broader pheochromocytoma-paraganglioma (PPGL) spectrum, which includes adrenal pheochromocytomas and sympathetic or parasympathetic extra-adrenal PGLs. Head and neck PGLs (HNPGLs) account for approximately 3% of all PGLs and predominantly originate from the parasympathetic paraganglia, most frequently at the carotid body, followed by the jugular bulb, tympanic plexus, and the ganglion nodosum of the vagus nerve [1,2]. Clinically, carotid body tumors (CBTs) are often indolent and present as slow-growing, painless lateral neck masses; however, proximity to major vessels and lower cranial nerves may create substantial diagnostic and therapeutic complexity even when lesions are histologically low grade [3,4].

Modern PPGL management increasingly emphasizes systematic endocrine and genetic assessment because HNPGLs may be hereditary, multicentric, metachronous, associated with pheochromocytoma or extra-head-and-neck PGLs across the lifespan, and occasionally catecholamine-secreting [5,6,7,8]. Plasma-free or urinary fractionated metanephrines are recommended as initial biochemical tests in suspected PPGL, and functional tumors require alpha-adrenergic blockade before surgery [9]. Although many parasympathetic HNPGLs are clinically nonsecretory, recent data indicate that clinically meaningful catecholamine secretion may be present in approximately 7.7% to 9.2% of HNPGLs, particularly among CBTs, cervical sympathetic PGLs, and SDHB-associated disease [6]. Therefore, characterization of multifocal HNPGL should include anatomical imaging, biochemical assessment, hereditary-risk evaluation, and consideration of whole-body functional imaging when multifocal or metastatic disease is suspected [3,10,11].

Synchronous involvement of CBTs and vagal PGLs (VPGLs) in the same patient remains rare, and reports combining bilateral CBTs with bilateral VPGLs are exceptional [12,13]. The objective of this report was to describe a rare case of synchronous bilateral CBTs and bilateral VPGLs with biochemical activity, histologically confirmed regional nodal metastasis, severe postoperative bradyarrhythmia, and delayed functional recovery, and to contextualize this case against the available literature on multicentric cervical PGLs.

2. Case Presentation

2.1. Initial Presentation and Diagnosis

A 33-year-old man with no history of chronic medical illness presented with bilateral neck masses that had gradually increased in size over 2 years. There was no history of preceding hypertension, sustained arrhythmia, flushing, carcinoid-like symptoms, collapse/syncope, or hyperadrenergic crises before the initial imaging assessment. A positive family history was recorded, with relatives reported to have had neck masses treated by different methods, although no definite diagnosis had been established from the available family records. On 8 March 2020, initial diagnostic evaluation with computed tomography (CT) angiography, before catecholamine testing was completed, demonstrated bilateral enhancing lesions/tumors arising at the bifurcation of both carotid arteries, encasing the internal carotid arteries and splaying the external carotid arteries bilaterally (Figure 1). No contrast-associated adrenergic crisis occurred during or after CT angiography. The right-sided lesion measured approximately 6.5 × 4 cm and showed some necrotic change, whereas the left-sided lesion measured approximately 6.4 × 3.7 cm. At the time of the initial assessment, these lesions were considered CBTs. Given the potential for a functional PGL, biochemical screening was conducted. Plasma catecholamine levels were markedly elevated, with a noradrenaline level of 6430 pg/mL (reference range <750 pg/mL). Plasma free or urinary fractionated metanephrines, normetanephrines, methoxytyramine, dopamine, serotonin, and 5-hydroxyindoleacetic acid were not measured. A subsequent Metaiodobenzylguanidine (MIBG) scan was performed to screen for adrenal, extra-adrenal, or distant metastatic disease, which showed no evidence of distant metastases at that time.

Figure 1.

Figure 1

CT angiography of the neck on 8 March 2020 showing bilateral hypervascular carotid bifurcation masses with splaying of the carotid vessels, larger on the right side.

2.2. Pre-Operative Management and First Surgery

The patient was evaluated by the endocrinology team and underwent preoperative medical preparation. Prazosin was administered for alpha-adrenergic blockade before atenolol was added for rate control after alpha blockade had been initiated. This sequencing was used to reduce the risk of intraoperative hypertensive crisis in the setting of biochemical catecholamine excess. After an adequate period of medical preparation, a staged surgical approach was planned, beginning with the slightly larger right-sided tumor. Intraoperatively, the circumscribed tumor was identified at the carotid bifurcation. Multiple enlarged regional lymph nodes were also noted and excised. The procedure was completed without immediate neurovascular complications. Histopathological examination of the resected specimen confirmed PGL, with clear surgical margins and no capsular invasion. Lymph node assessment demonstrated metastatic disease, with two of four excised regional lymph nodes positive for PGL. Nodal stations, Ki-67 index, or the complete immunohistochemical panel were not specified in the first surgical pathology report.

2.3. Post-Operative Evaluation and Planning for Second Surgery

Following confirmation of histologically confirmed nodal metastatic disease, a staging CT scan of the neck, chest, and abdomen, including the adrenal regions, was performed and it did not identify adrenal lesions or distant visceral metastases in these regions. Retrospective review of the CT imaging, including coronal reconstructions, clarified the right-sided anatomy as two adjacent right parapharyngeal/cervical masses separated by a visible cleavage plane, rather than a single confluent lesion. In contrast, on the left side, a single mass was identified without a separating cleavage plane. Interval reassessment with magnetic resonance imaging (MRI) of the neck on 7 October 2020, demonstrated no substantial interval change in the cervical disease burden compared with prior imaging. The right-sided lesion measured 3.8 × 3.2 × 3.1 cm, and the left-sided lesion measured approximately 5 × 3.3 × 2.7 cm (Figure 2).

Figure 2.

Figure 2

Magnetic resonance imaging (MRI) of the neck demonstrates bilateral paraganglioma-related lesions. (a) Axial contrast-enhanced MRI showing bilateral hypervascular masses at the carotid bifurcations with characteristic vascular flow voids. (b) Coronal view demonstrating the extent of the lesions and their relationship to adjacent vascular structures, with separation of right-sided lesions suggesting distinct tumors. (c) Sagittal view highlighting mass effect on the upper aerodigestive tract, including indentation of the hypopharynx.

The right-sided tumor indented the right hypopharynx and caused slight narrowing of the lumen at the level of the oropharynx. Multiple signal-void areas were present within the tumor, attributed in the report to prominent vessels. Diffusion imaging demonstrated multiple slightly prominent lymph nodes in the posterior triangle with post-contrast enhancement. The MRI also described a small oval T2-hyperintense focus in the right side of the T2 vertebral body, measuring approximately 4 × 34 mm, which did not suppress on fat-saturated images and enhanced after intravenous contrast (Figure 3). The overall impression was bilateral CBTs and bilateral VPGLs with slightly prominent bilateral cervical lymphadenopathy in the deep posterior triangles and a small focal T2 vertebral body lesion that was radiologically suspicious for possible metastasis but was not histologically confirmed.

Figure 3.

Figure 3

Schematic illustration of the distribution of synchronous bilateral carotid body and bilateral vagal paragangliomas. Enlarged right cervical lymph nodes represent histologically confirmed nodal metastatic involvement, and the T2 vertebral body lesion indicates a radiologically suspected site of possible metastasis. This schematic is not drawn to scale. The schematic was initially hand-drawn by the authors and subsequently enhanced using FigureLabs (https://www.figurelabs.ai/) and BioRender (https://www.biorender.com/). Created in BioRender. Alanezi et.al. (2026) https://BioRender.com/h42n006.

Initial cross-sectional imaging was interpreted as demonstrating a single large parapharyngeal mass; however, intraoperative findings and subsequent detailed radiologic review established the presence of two anatomically distinct lesions, consistent with synchronous bilateral CBTs and bilateral VPGLs, biochemical activity, and regional lymph node metastasis. On retrospective review, subtle splaying of the carotid bifurcation and a separate cranial extension along the expected course of the vagus nerve were appreciated, although these findings had not been clearly distinguishable preoperatively because of mass effect. The coexistence of bilateral CBTs and bilateral VPGLs was therefore definitively recognized only after integration of operative findings with detailed radiological re-review and MRI. The case was discussed in a multidisciplinary team meeting involving vascular surgery, head and neck surgery, and endocrinology. A decision was made to proceed with surgery for left-sided neck mass excision with modified neck dissection and possible right-sided completion at a later stage. The patient was again prepared for surgery and was given the same antihypertensive medications.

2.4. Second Surgery and Post-Operative Course

On 12 October 2020, the patient underwent left-sided carotid mass excision with neck dissection. Intraoperatively, the tumor was found to be densely adherent to the left vagus nerve. To preserve the continuity and potential function of the nerve, complete resection was not feasible, and a partial debulking of the mass was performed. A full left neck dissection was completed on the left side. Histopathological examination of the specimen confirmed a PGL with a Ki-67 index of approximately 2%. All examined left-sided lymph nodes were negative for tumor involvement (jugular, 0/3; level IIa, 0/1; levels III and VI, 0/12). Postoperatively, the patient was transferred to the intensive care unit (ICU) for monitoring and was initially extubated successfully.

Upon a trial of oral water intake, severe coughing occurred, with no reported aspiration, followed by profound bradycardia and a near-arrest episode that necessitated re-intubation. In the ICU, he experienced multiple episodes of severe bradycardia, with heart rates decreasing to 30 beats per minute. Cardiology consultation was obtained, and a temporary pacemaker was inserted. Bilateral vocal cord paralysis was also documented, likely reflecting vagal-region involvement and surgical manipulation; the left-sided deficit occurred postoperatively, whereas the right-sided deficit was attributed to tumor-related mass effect or prior right-sided surgical manipulation that had not been clinically apparent. His condition gradually improved, and no fever or other apparent signs of infection were documented. Continued cardiology follow-up led to a recommendation for permanent pacemaker insertion, which was subsequently performed. Thereafter, his overall condition improved. He reported some dizziness but was able to walk without severe bradycardia, and his heart rate was documented as 70 beats per minute; he was then transferred to the ward. He was maintained on procyclidine 2.5 mg orally twice daily, later increased to 5 mg orally twice daily. The wound healed without reported complications.

2.5. Follow-Up

Follow-up CT of the neck on 19 November 2020 showed that the residual left-sided mass had regressed in size to 3.0 × 1.6 cm after debulking, while the right-sided lesion showed no interval change in size. The study also suggested left vocal cord paralysis, based on medialization of the left vocal cord and an enlarged laryngeal ventricle. Serial postoperative catecholamine or metanephrine testing was not performed after each operation. No postoperative somatostatin receptor imaging with OctreoScan or 68Ga-DOTATATE PET/CT was undertaken, and adjuvant octreotide therapy was not initiated. By approximately 1 year postoperatively, the permanent pacemaker had been removed, and the patient reported no further hoarseness or choking episodes. Excision of the right vagal tumor was offered by the head and neck surgeon; however, the patient declined after counseling regarding potential complications. At subsequent follow-up, Magnetic Resonance Angiography (MRA) of the neck on 15 January 2026 reportedly demonstrated no change in size compared with the most recent prior imaging (2023) (Figure 4), and CT of the chest and abdomen showed no evidence of visceral metastasis, as shown in Table 1.

Figure 4.

Figure 4

(a) Axial Magnetic Resonance Angiography (MRA) of the neck demonstrating postoperative status with no residual tumor at the carotid bifurcation, consistent with complete resection of the carotid body tumor. (b) Coronal MRA view showing persistent residual mass along the expected course of the vagus nerve, consistent with residual vagal paraganglioma following prior partial debulking, with no interval progression or new lesions identified.

Table 1.

Timeline of clinical presentation, diagnostic evaluation, surgical management, pathology, postoperative course, follow-up imaging, and approximate intervals in a patient with bilateral cervical paraganglioma-related masses.

Date/Approximate Interval Clinical Milestone Key Documented Details
Before 8 March 2020 (approximately 2-year symptom history before baseline imaging) Initial presentation The patient presented with bilateral neck masses that had gradually increased in size over 2 years.
8 March 2020 (baseline imaging) Initial CT angiography Bilateral enhancing lesions/tumors were identified at the bifurcation of both carotid arteries, encasing the internal carotid arteries and splaying the external carotid arteries bilaterally.
13 August 2020 (approximately 5 months after baseline CT) First operation Excision of a right CBT was performed. Intraoperatively, a large circumscribed CBT with multiple enlarged lymph nodes was identified.
After 13 August 2020 (post-first operation) First histopathology Histopathological review, including second-opinion assessment, showed metastatic PGL, with two of four lymph nodes positive for tumor.
7 October 2020 (approximately 8 weeks after first operation) MRI neck Bilateral lobulated mass. The right-sided mass indented the right hypopharynx and mildly narrowed the oropharyngeal lumen. Multiple signal-void areas were present within the tumors. Slightly prominent posterior triangle lymph nodes were noted. A small enhancing T2 vertebral body lesion was also reported as concerning for possible metastasis.
After MRI review (October 2020) Revised anatomical interpretation Initial cross-sectional imaging had suggested a single large parapharyngeal mass; however, intraoperative findings and subsequent detailed radiologic review established two anatomically distinct lesions, consistent with a CBT and a VPGL.
1 October 2020 (approximately 7 weeks after first operation) Second admission The patient was admitted for the second surgery. Hematology, endocrinology, ENT, and cardiology teams were consulted, and he was cleared for surgery.
12 October 2020 (approximately 2 months after first operation) Second operation A well-circumscribed tumor at the carotid bifurcation was resected, consistent with a CBT, and a second, anatomically distinct mass was identified that was predominantly adherent to the left vagus nerve. Debulking was performed, and a remnant was left in situ to preserve nerve continuity. Full neck dissection was completed.
After 12 October 2020 (post-second operation) Second histopathology Histopathology showed PGL with a Ki-67 index of approximately 2%. All left-sided neck lymph nodes harvested were uninvolved by tumor.
Immediate postoperative period (October 2020) ICU course The patient was monitored in the intensive care unit and was initially extubated successfully.
Early postoperative period (October 2020) Major complication After drinking water, he developed severe coughing followed by severe bradycardia with near arrest, necessitating reintubation and continued monitoring.
Cardiac management Several episodes of bradycardia down to 30 beats/min were documented. Cardiology review was obtained, and a temporary pacemaker was inserted and maintained for several days.
Later postoperative period (late 2020 onward) Permanent pacing Cardiology follow-up led to recommendation for permanent pacemaker insertion, which was subsequently performed.
Recovery status Clinical condition gradually improved. The patient reported some dizziness but was able to ambulate without severe bradycardia; heart rate was documented as 70 beats/min. The wound was healing well. Procyclidine 2.5 mg orally twice daily was prescribed and later increased to 5 mg orally twice daily.
Laryngeal complication Postoperative hoarseness was documented, and bilateral vocal cord paralysis was diagnosed.
19 November 2020 (approximately 5 weeks after second operation) Follow-up CT neck There was a reduction in the size of both left- and right-sided lesions compared with the initial imaging, with no residual tumor identified at the carotid bifurcation on either side
2023 (approximately 3 years after surgery) MRI The permanent pacemaker was removed, and the patient reported no further hoarseness or choking episodes, with good swallowing.
Jan 2026 (approximately 5 years after surgery) Late follow-up imaging and staging MRA neck reportedly showed no change in size compared with the most recent prior imaging (2023), and CT chest/abdomen showed no evidence of metastasis.

CT, computed tomography; ENT, ear, nose, and throat; ICU, intensive care unit; MRI, magnetic resonance imaging; MIBG, metaiodobenzylguanidine; MRA, Magnetic Resonance Angiography; PGL, paraganglioma.

3. Discussion

Although many HNPGLs follow an indolent course, their clinical importance lies in their hypervascularity, proximity to major vessels and lower cranial nerves, potential hereditary basis, occasional catecholamine secretion, and the functional consequences of treatment [3,14]. Multicentricity has been reported in 10% to 20% of sporadic cases and may approach 80% in familial PGL syndromes [15,16,17]. Within this spectrum, synchronous CBTs and vagal involvement in the same patient is distinctly uncommon, and the literature remains dominated by isolated case reports rather than robust comparative series (Table 2) [12,13,18]. Therefore, the present case is notable because it combined multicentric bilateral cervical distribution, biochemical activity, histologically confirmed regional nodal metastasis, complex operative anatomy, and severe postoperative cardiolaryngeal morbidity.

Table 2.

Published case reports of bilateral or multicentric cervical paragangliomas involving carotid body and/or vagal tumors.

Study; Country Age/Sex FHx/Genetics Functional Status Presentation Imaging/Distribution Metastasis Management Complications Pathology/Outcome
Lemaire et al., 1999; Belgium [19] 24/M Yes; pedigree suggestive of hereditary PGL with maternal imprinting; pre-SDH linkage only NR Initial left cervical swelling Age 24: left JTP + left CBT; age 26: right CBT + VPGL; age 30: bilateral cervical recurrence with aortopulmonary and mesogastric PGLs No distant metastasis; multifocal recurrent/systemic disease Multiple resections Permanent neurologic sequelae Histology confirmed PGLs; recurrent metachronous multifocal course
Velegrakis et al., 2001; Germany [20] 75/F NR NF biochemically; urinary catecholamines, metanephrines, and VMA normal Suspected metastatic thyroid carcinoma; rapidly enlarging bilateral lateral neck masses (2 months); no pre-op lower CN deficits CT: 2 large lateral cervical tumors displacing carotids; right extended to upper mediastinum; left paratracheal thyroid lesion. Intra-op: bilateral vagus nerve encasement No nodal/distant metastasis from VPGLs Planned thyroidectomy + bilateral neck dissection; total thyroidectomy; right VPGL en bloc resection; left wedge biopsy only Persistent hoarseness/right vocal cord paralysis; died POD30 from extensive MI Right tumor: VPGL with hemorrhage/central necrosis, no atypia or increased mitoses; chromogranin A+. Left biopsy: PGL. Thyroid: papillary microcarcinoma
Pandey et al., 2002; India [21] 23/F Sporadic; FHx/genetics not detailed NR Evening fever, hoarseness, throat foreign-body sensation Right VPGL + left CBT; CT: bilateral enhancing carotid bifurcation masses; right 4.7 × 2.5 cm with vocal cord involvement and airway narrowing; left smaller Reactive left level II–III nodes; no distant metastasis Pre-op lipiodol embolization; staged surgery: right VPGL excision + modified neck dissection, then left CBT excision with partial carotid wall resection/primary repair After second surgery: PE, ARDS, ventilatory support; died POD4 of multiorgan failure Biopsy/resection consistent with PGL; NSE positive. Left specimen showed infiltrative nested neoplasm with necrosis; nodes reactive
Karatas et al., 2008; Turkey [13] 49/M Non-familial NF Bilateral neck masses for 3 years with recent tenderness; pulsatile with limited vertical mobility; CN exam initially intact MRI/Doppler US: vascular masses at both carotid bifurcations (right 3 × 3 × 2 cm; left 4.5 × 3 × 5 cm); incidental left VPGL found intra-op No nodal/distant metastasis Pre-op angiography + PVA embolization; staged surgery: left CBT + left VPGL excision first (left vagus sacrificed), then right CBT excision 6 months later Likely unilateral vocal fold dysfunction; medialization thyroplasty at 4 months Histology confirmed left CBT + VPGL and right CBT
Kataria et al., 2010; India [12] 20/M NR Urinary metanephrine not elevated Slow-growing bilateral neck masses for 8 years; right neck pain, dysphagia, mouth breathing, hoarseness; left hemitongue atrophy/fasciculations MRI: right Shamblin III CBT (8 × 6 cm clinically) extending to skull base and compressing oro-/hypopharynx; left VPGL (3 × 2 cm clinically) from carotid bifurcation to skull base with focal dural involvement; bilateral level III/IV nodes; octreotide scan positive Left VPGL considered malignant with nodal involvement; no distant metastasis Surgery considered too morbid; IGRT/IMRT 50.4 Gy in 28 fractions to bilateral gross disease/nodes Grade 2 mucositis during RT No surgical specimen; 3 months: mild regression/stable disease; 16 months: symptomatic and clinical improvement
Bakshi et al., 2019; India [22] 45/M FHx not reported; genetics NR NR Gradually enlarging left upper-neck mass for 3 years; otherwise asymptomatic CECT/DSA: bilateral carotid bifurcation lesions with splaying/tumor blush; presumed CBT pre-op; intra-op left carotid + vagal involvement; post-op described as bilateral carotid PGLs with left VPGL No metastasis Excision of left carotid and vagal tumors; discharged day 7 Left vocal cord palsy; no aspiration; speech therapy Otherwise uneventful recovery; no recurrence at 2 years
Yepuri et al., 2021; USA [23] 58/F Positive FHx (brother with CBT); no germline testing; SDHB IHC loss in thyroid lesion NR Presented with thyroid nodule; no palpable cervical masses Prior right VPGL resection 24 years earlier and right CBT resection 13 years earlier; current US: 24 × 8 × 23 mm vascular isthmus/left-lobe nodule; MRI positive; CT chest/abdomen/pelvis negative No local recurrence or distant disease Total thyroidectomy No surgical complications Primary thyroid PGL confirmed by pathology/IHC; disease-free at 5 years
Moscona-Nissan et al., 2021; Mexico [24] 61/F NR NF Right pulsatile painless neck mass for 1 year Angio-CT: right hypervascular carotid-space mass 4.2 × 3.6 × 3.4 cm to C5, encasing proximal ECA; left carotid bifurcation lesion 6.4 × 5.8 mm; right Shamblin II; angiography confirmed tumor blush No metastasis Novel pre-op endovascular strategy: covered PTFE stent-graft in right common/proximal ICA + balloon plasty; surgery planned Arterial spasm/possible distal dissection during procedure; post-procedure MRI/FLAIR negative for ischemia Histology and long-term surgical outcome not available; short follow-up unremarkable
Duan et al., 2022; China [25] 58/F FHx negative; genetics NR NF Incidentally diagnosed 3 years earlier; later reported only neck-swelling sensation CTA: bilateral CBTs (right 2.6 × 1.8 × 1.3 cm, Shamblin II; left 1.1 × 0.9 × 0.9 cm, Shamblin I) No malignancy Staged surgery planned; right CBT resection first by subadventitial dissection; left observed at reported follow-up; no pre-op embolization or pacemaker Intra-op asystole/cardiac arrest with hypotension from carotid sinus hypersensitivity; recovered with CPR, atropine, topical lidocaine, and stopping manipulation Histology/IHC confirmed PGL; no neurologic sequelae at 1 month
Sakaran et al., 2024; Malaysia [26] NR/M SDHD mutation positive; FHx NR NR Bilateral painless palpable neck masses for 2 years CECT: bilateral carotid bulb masses with Lyre sign (left 3 × 2.5 cm; right 2 × 1.2 cm); intra-op features consistent with Shamblin II No metastasis Staged excision: left CBT then right CBT 3 months later; hypoglossal, ansa cervicalis, and vagus preserved in first surgery Transient left hypoglossal palsy NR
Cidral et al., 2025; Brazil [27] 49/F No FHx; genetics NR NR Bilateral neck masses for 1 year with recurrent syncope; no pain, dysphagia, or dysphonia CTA/angiography: bilateral hypervascular carotid-space masses; left larger; both Shamblin III; cerebral blood-flow study unchanged bilaterally No nodal/distant metastasis No pre-op embolization; staged bilateral surgery: right then left 2 months later; subadventitial dissection; blood loss 400 and 600 mL No postoperative neurologic deficit reported Histology confirmed bilateral PGLs; article also labeled both grade III, but modern pathology details were not reported

ARDS, acute respiratory distress syndrome; CBT, carotid body tumor; CECT, contrast-enhanced computed tomography; CN, cranial nerve; CTA, computed tomography angiography; DSA, digital subtraction angiography; ECA, external carotid artery; FHx, family history; ICA, internal carotid artery; IHC, immunohistochemistry; IGRT, image-guided radiotherapy; IMRT, intensity-modulated radiotherapy; JTP, jugulotympanic paraganglioma; MI, myocardial infarction; NF, non-functional; NR, not reported; PE, pulmonary embolism; PGL, paraganglioma; POD, postoperative day; PTFE, polytetrafluoroethylene; PVA, polyvinyl alcohol; RT, radiotherapy; SDH, succinate dehydrogenase; VPGL, vagal paraganglioma; VMA, vanillylmandelic acid.

Current evidence supports a hereditary framework for a substantial proportion of HNPGLs, and guideline-oriented studies recommend genetic counseling and consideration of germline testing for all patients with PGL, particularly when the disease is bilateral, multifocal, metastatic, or presents at a relatively young age [3,28]. Up to 40% of HNPGLs are associated with genetic mutations, predominantly in the succinate dehydrogenase (SDH) complex genes (SDHA, SDHB, SDHC, SDHD) [3,29,30]. SDHD mutations are classically associated with multifocal parasympathetic HNPGL and demonstrate a parent-of-origin effect, with disease manifesting predominantly after paternal inheritance. In contrast, SDHB mutations are more often associated with extra-adrenal sympathetic PGLs and a higher risk of metastatic disease than SDHD-associated tumors [31,32,33]. In the large Papaspyrou series of 175 patients, multifocality and mutation-positive disease were important recurring themes in clinical evaluation [17]. More recently, Bellamkonda et al. analyzed 49 patients with bilateral HNPGLs comprising 116 tumors, including 90 CBTs and 15 VPGLs, further highlighting that bilateral disease is a distinct management subset [34]. These observations are highly relevant to the present patient because he presented at 33 years of age with bilateral cervical masses and a positive family history of relatives with neck masses. Although formal molecular testing had not been performed, this phenotype strongly supports referral for genetic counseling, germline testing, family evaluation, and long-term surveillance [35].

HNPGLs typically present as slow-growing, painless, pulsatile lateral neck masses. Symptoms often arise from the mass effect on adjacent lower cranial nerves (CN IX-XII), leading to hoarseness, dysphagia, or Horner’s syndrome [2]. The present patient had a 2-year history of progressively enlarging bilateral neck masses, consistent with the slow growth pattern reported for these tumors (mean growth rate of 1–2 mm/year) [36]. Most HNPGLs have historically been considered non-secretory; however, contemporary data indicate that clinically meaningful catecholamine excess is not negligible [6,28,37]. Smith et al. reported that clinically significant catecholamine secretion was present in 9.2% of patients and 7.7% of tumors, with enrichment among CBTs and SDHB-associated disease [6]. This finding is clinically important because biochemical activity influences perioperative preparation, cardiovascular risk, and interpretation of symptoms [38]. In the current patient, the markedly elevated noradrenaline level justified preoperative alpha- then beta-blockade and distinguishes this case from many published HNPGL reports in which biochemical activity was absent or not reported.

The anatomical distribution and size of HNPGLs dictate the surgical approach and associated morbidity. This case featured bilateral lesions initially thought to be isolated CBTs. However, intraoperative findings and retrospective imaging review revealed a complex combination of bilateral CBTs and bilateral VPGLs. CBTs characteristically arise at the carotid bifurcation, splay the internal and external carotid arteries (Lyre sign), and are graded by the Shamblin classification according to carotid vessel encasement [39]. VPGLs typically originate more cephalad from the nodose ganglion and displace the internal carotid artery anteriorly [12]. The synchronous presence of four anatomically distinct parapharyngeal and cervical tumors suggests marked multifocality, a phenotype reported in SDHx-associated disease [4].

Standard anatomical evaluation relies on contrast-enhanced CT and MRI, which define carotid bifurcation splaying, cranial extension, skull-base proximity, and vascular encasement [3,37]. However, in multifocal or closely adjacent lesions, anatomical distinction may be difficult when one tumor distorts the tissue planes of another. In the present case, the diagnosis of synchronous bilateral CBTs and bilateral VPGLs was established only after integration of operative findings, MRI, and detailed radiological re-review. The modern diagnostic pathway has also evolved beyond anatomic imaging alone. Lin et al. recommended 68Ga-DOTATATE PET/CT as first-line functional imaging when multifocal or metastatic disease is suspected [3]. Janssen et al. demonstrated that 68Ga-DOTATATE PET/CT localized more HNPGL lesions than conventional anatomical imaging and other functional modalities in parasympathetic HNPGLs [10]. Although MIBG scintigraphy did not demonstrate adrenal or distant uptake at initial work-up, current evidence supports 68Ga-DOTATATE PET/CT as the preferred functional imaging modality when multifocal or metastatic HNPGL is suspected [11].

Multifocality should not be equated with metastatic behavior. In PPGL, metastatic disease is defined by tumor presence in sites lacking normal paraganglionic tissue rather than by local invasion or histological features alone [3,37]. Clinically evident metastatic behavior occurs in approximately 5% of CBTs, whereas VPGLs appear to carry a higher metastatic propensity, with reviews citing metastatic rates of roughly 10% to 19% [37,40]. In the present case, PGL involvement in two of four regional lymph nodes after the first operation established histologically confirmed regional metastatic disease. By contrast, the T2 vertebral focus was radiologically suspicious but was not biopsy-confirmed; therefore, it should be regarded as a possible, rather than definitive, distant metastasis. This distinction differentiates the current patient from several comparator reports describing combined CBTs/VPGLs without documented nodal metastatic spread [12,13,41]. Long-term survival for metastatic HNPGLs is variable; lymph node metastases may follow an indolent course, whereas distant metastases involving bone or lung may be associated with worse outcomes and may require consideration of systemic or radionuclide-based therapies in selected patients [42].

Management of HNPGLs has shifted from a uniformly aggressive surgical approach toward individualized decision-making that balances tumor control against long-term function [14]. Factors influencing treatment choice include age, comorbidity, tumor size and site, bilaterality, growth, secretory status, baseline cranial nerve function, metastatic behavior, and patient preference [14,28]. CBTs and VPGLs do not carry equivalent operative risk. In the bilateral HNPGL series by Bellamkonda et al., CBTs had the lowest risk of postoperative cranial nerve deficits after surgery compared with vagal and jugular lesions [34]. Del Guercio et al. reported preoperative cranial nerve palsy in 36% of patients, new postoperative nerve dysfunction in 16%, and persistent deficits in 12% in a mixed cervical series managed at an experienced center [43]. For catecholamine-secreting tumors, preoperative alpha-adrenergic blockade before beta-blockade is recommended to reduce perioperative adrenergic risk [9]. For bilateral tumors, concurrent bilateral resection is generally avoided because of the risk of bilateral lower cranial nerve palsy and baroreflex failure [44]. The staged, single-center multidisciplinary strategy used in the present case, with right-sided resection performed first and left-sided surgery undertaken subsequently after recognition of dense vagal adherence, is consistent with a function-conscious approach in bilateral or multicentric HNPGLs [45]. Complete resection was not pursued at the cost of definite nerve sacrifice; instead, partial debulking was undertaken to preserve nerve continuity. This approach aligns with literature supporting selective resection, radiotherapy, or surveillance in anatomically high-risk lesions rather than routine radical excision [28,40]. Functional morbidity remains one of the most important determinants of outcome in HNPGL management, especially when the vagus nerve is involved. Lower cranial nerve dysfunction may manifest as hoarseness, dysphagia, aspiration risk, shoulder dysfunction, or the need for voice and swallowing interventions. Neskey et al. emphasized that postoperative outcomes after HNPGL resection should be judged not only by tumor control, but also by functionally meaningful endpoints such as feeding-tube or tracheostomy dependence, need for vocal fold medialization, and cerebrovascular complications [46]. In the current case, the postoperative bilateral vocal cord paralysis and transient swallowing difficulty reflected the recognized functional burden of surgery for vagal-region disease. The most distinctive complication was the severe postoperative bradyarrhythmia requiring temporary and then permanent pacing, followed by later pacemaker removal after recovery. Major bradycardic events of this severity are uncommon in the HNPGL literature but biologically plausible through carotid sinus hypersensitivity, vagal reflex activation, or manipulation of autonomic structures during surgery [47]. Bauer et al. described carotid sinus hypersensitivity after preoperative embolization of a CBT that required temporary pacemaker placement before definitive resection [48], and Duan et al. reported intraoperative cardiac arrest during CBT resection attributable to carotid sinus hypersensitivity [25]. The present case indicates that profound postoperative bradycardia may occur in parallel with vagal-related laryngeal dysfunction after complex HNPGLs surgery and that both complications may improve over prolonged multidisciplinary follow-up.

Limitations of the Current Case Report

Several limitations should be acknowledged. First, endocrine characterization was incomplete; biochemical evaluation showed markedly elevated noradrenaline, but plasma or urinary metanephrines, normetanephrine, dopamine, methoxytyramine, serotonin/5-hydroxyindoleacetic acid, and serial postoperative biochemical values were not measured. Second, germline testing of the patient and endocrine/genetic evaluation of relatives were not performed despite young age, family history, bilateral disease, multifocality, and metastatic nodal involvement. Third, radiological and pathological characterization relied on formal reports because source MIBG images, pathological slides, detailed immunohistochemistry, and pathological micrographs were not provided for publication. Additionally, recognized predictors of difficult resections, such as the distance of the tumor to the base of the skull [49], were not assessed. Fourth, the T2 vertebral lesion was radiologically suspicious but not histologically confirmed. These limitations reinforce the need for comprehensive biochemical testing, genetic counseling, functional imaging, family assessment, and structured long-term surveillance in similar cases.

4. Conclusions

This real-world case demonstrates a rare presentation of synchronous bilateral CBTs with bilateral VPGLs in a young patient with positive family history, biochemical activity, histologically confirmed regional nodal metastasis, staged surgical management, severe postoperative bradyarrhythmia, bilateral vocal cord dysfunction, and delayed functional recovery. Several practical messages can be drawn. First, bilateral or multifocal HNPGLs should prompt consideration of hereditary disease, genetic counseling, family evaluation, and long-term surveillance. Second, careful re-review of imaging and, where available, contemporary functional imaging may reveal multicentric disease not fully appreciated on initial assessment. Third, treatment should be individualized, particularly when vagal involvement creates a high risk of permanent lower cranial nerve morbidity. Finally, rare cardiovascular complications such as carotid sinus hypersensitivity or vagally mediated bradyarrhythmia should remain within the perioperative differential in complex HNPGL surgery. Despite the severe presentation, the patient’s subsequent functional improvement, pacemaker removal, stable residual cervical disease, and absence of visceral metastasis on late chest/abdominal imaging suggest a favorable clinical course to date, while continuing to justify prolonged multidisciplinary surveillance.

Abbreviations

The following abbreviations are used in this manuscript:

ARDS acute respiratory distress syndrome
CBT Carotid body tumor
CT Computed tomography
CTA Computed tomography angiography
MRI Magnetic resonance imaging
HNPGL Head and neck paraganglioma
VPGL Vagal paraganglioma
PGL Paraganglioma
MIBG Metaiodobenzylguanidine
VMA Vanillylmandelic acid
PTFE Polytetrafluoroethylene

Author Contributions

N.A. and T.A. drafted the main manuscript text. Y.A., M.D., H.G., M.A. and O.T.A. contributed to the literature review and preparation of the figures. All authors have read and agreed to the published version of the manuscript.

Institutional Review Board Statement

Institutional ethics approval was waived for this study, due to it being a single-case report and in accordance with local institutional policy.

Informed Consent Statement

Written informed consent has been obtained from the patient(s) to publish this paper.

Data Availability Statement

All data generated or analyzed during this study are included in this published article. Additional details are available from the corresponding author upon reasonable request.

Conflicts of Interest

The authors declare no conflicts of interest.

Funding Statement

The work was supported and funded by the Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University (IMSIU) (grant number IMSIU-DDRSP2601).

Footnotes

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

References

  • 1.Graham N.J., Smith J.D., Else T., Basura G.J. Paragangliomas of the head and neck: A contemporary review. Endocr. Oncol. 2022;2:R153. doi: 10.1530/EO-22-0080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Prasad S.C., Paties C.T., Pantalone M.R., Mariani-Costantini R., Sanna M. Paraganglioma: A Multidisciplinary Approach. Exon Publications; Brisbane, Australia: 2019. Carotid Body and Vagal Paragangliomas: Epidemiology, Genetics, Clinicopathological Features, Imaging, and Surgical Management; pp. 81–98. [DOI] [PubMed] [Google Scholar]
  • 3.Lin E.P., Chin B.B., Fishbein L., Moritani T., Montoya S.P., Ellika S., Newlands S. Head and Neck Paragangliomas: An Update on the Molecular Classification, State-of-the-Art Imaging, and Management Recommendations. Radiol. Imaging Cancer. 2022;4:E210088. doi: 10.1148/rycan.210088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Benn D.E., Robinson B.G., Clifton-Bligh R.J. 15 YEARS OF PARAGANGLIOMA: Clinical manifestations of paraganglioma syndromes types 1–5. Endocr. Relat. Cancer. 2015;22:T91. doi: 10.1530/ERC-15-0268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Offergeld C., Brase C., Yaremchuk S., Mader I., Rischke H.C., Gläsker S., Schmid K.W., Wiech T., Preuss S.F., Suárez C., et al. Head and neck paragangliomas: Clinical and molecular genetic classification. Clinics. 2012;67:19–28. doi: 10.6061/clinics/2012(sup01)05. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Smith J.D., Ellsperman S.E., Basura G.J., Else T. Re-evaluating the prevalence and factors characteristic of catecholamine secreting head and neck paragangliomas. Endocrinol. Diabetes Metab. 2021;4:e00256. doi: 10.1002/edm2.256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Zheng X., Wei S., Yu Y., Xia T., Zhao J., Gao S., Li Y., Gao M. Genetic and clinical characteristics of head and neck paragangliomas in a Chinese population. Laryngoscope. 2012;122:1761–1766. doi: 10.1002/lary.23360. [DOI] [PubMed] [Google Scholar]
  • 8.Richter S., Qiu B., Ghering M., Kunath C., Constantinescu G., Luths C., Pamporaki C., Bechmann N., Meuter L., Kwapiszewska A., et al. Head/neck paragangliomas: Focus on tumor location, mutational status and plasma methoxytyramine. Endocr. Relat. Cancer. 2022;29:213–224. doi: 10.1530/ERC-21-0359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Lenders J.W.M., Duh Q.-Y., Eisenhofer G., Gimenez-Roqueplo A.-P., Grebe S.K.G., Murad M.H., Naruse M., Pacak K., Young W.F., Jr. Pheochromocytoma and paraganglioma: An endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 2014;99:1915–1942. doi: 10.1210/jc.2014-1498. [DOI] [PubMed] [Google Scholar]
  • 10.Janssen I., Chen C.C., Taieb D., Patronas N.J., Millo C.M., Adams K.T., Nambuba J., Herscovitch P., Sadowski S.M., Fojo A.T., et al. 68Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT/MRI. J. Nucl. Med. 2016;57:186–191. doi: 10.2967/jnumed.115.161018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Maurice J.B., Troke R., Win Z., Ramachandran R., Al-Nahhas A., Naji M., Dhillo W., Meeran K., Goldstone A.P., Martin N.M., et al. A comparison of the performance of 68Ga-DOTATATE PET/CT and 123I-MIBG SPECT in the diagnosis and follow-up of phaeochromocytoma and paraganglioma. Eur. J. Nucl. Med. Mol. Imaging. 2012;39:1266–1270. doi: 10.1007/s00259-012-2119-7. [DOI] [PubMed] [Google Scholar]
  • 12.Kataria T., Bisht S.S., Mitra S., Abhishek A., Potharaju S., Chakarvarty D. Synchronous malignant vagal paraganglioma with contralateral carotid body paraganglioma treated by radiation therapy. Rare Tumors. 2010;2:57–59. doi: 10.4081/rt.2010.e21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Karatas E., Sirikci A., Baglam T., Mumbuc S., Durucu C., Tutar E., Kanlikama M. Synchronous bilateral carotid body tumor and vagal paraganglioma: A case report and review of literature. Auris Nasus Larynx. 2008;35:171–175. doi: 10.1016/j.anl.2007.05.007. [DOI] [PubMed] [Google Scholar]
  • 14.Cleere E.F., Martin-Grace J., Gendre A., Sherlock M., O’Neill J.P. Contemporary management of paragangliomas of the head and neck. Laryngoscope Investig. Otolaryngol. 2021;7:93. doi: 10.1002/lio2.706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Thabet M.H., Kotob H. Cervical paragangliomas: Diagnosis, management and complications. J. Laryngol. Otol. 2001;115:467–474. doi: 10.1258/0022215011908180. [DOI] [PubMed] [Google Scholar]
  • 16.Sobol S.M., Dailey J.C. Familial multiple cervical paragangliomas: Report of a kindred and review of the literature. Otolaryngol. Head Neck Surg. 1990;102:382–390. doi: 10.1177/019459989010200413. [DOI] [PubMed] [Google Scholar]
  • 17.Papaspyrou K., Mewes T., Rossmann H., Fottner C., Schneider-Raetzke B., Bartsch O., Schreckenberger M., Lackner K.J., Amedee R.G., Mann W.J. Head and neck paragangliomas: Report of 175 patients (1989–2010) Head. Neck. 2012;34:632–637. doi: 10.1002/hed.21790. [DOI] [PubMed] [Google Scholar]
  • 18.Kawanabe S., Katabami T., Oshima R., Yanagisawa N., Sone M., Kimura N. A rare case of multiple paragangliomas in the head and neck, retroperitoneum and duodenum: A case report and review of the literature. Front. Endocrinol. 2023;13:1054468. doi: 10.3389/fendo.2022.1054468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Lemaire M., Persu A., Hainaut P., De Plaen J.F. Hereditary paraganglioma. J. Intern. Med. 1999;246:113–116. doi: 10.1046/j.1365-2796.1999.00519.x. [DOI] [PubMed] [Google Scholar]
  • 20.Velegrakis G., Kalikakis G., Karampekios S., Stefanaki K., Helidonis E. Bilateral paraganglioma of the vagus nerve. HNO. 2001;49:471–475. doi: 10.1007/s001060170099. [DOI] [PubMed] [Google Scholar]
  • 21.Pandey M., Chandramohan K., Sebastian P., Ramachandran K. An unusual bilateral cervical paraganglioma: A case report. Int. J. Oral. Maxillofac. Surg. 2002;31:334–336. doi: 10.1054/ijom.2001.0196. [DOI] [PubMed] [Google Scholar]
  • 22.Bakshi J., Goyal A.K., Vir D., Panda N.K. Multiple paragangliomas involving carotid body and vagal region: A sporadic case. Otorhinolaryngol. Head Neck Surg. 2019;4:1–3. doi: 10.15761/OHNS.1000197. [DOI] [Google Scholar]
  • 23.Yepuri N., Vanga G.R., Naous R., Kinthala S. Thyroid paraganglioma in a patient with a history of carotid and vagal paraganglioma: Metastatic or primary tumor? J. Surg. Case Rep. 2021;2021:rjab102. doi: 10.1093/jscr/rjab102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Moscona-Nissan A., A Saldívar-Rodea C., Enríquez-García R., Rincón-Ángel L.I., Calzada A.N., Seidman-Sorsby A., Cruz-Zermeño M. Bilateral carotid body tumor case: A novel preoperative management. Radiol. Case Rep. 2022;17:1021–1029. doi: 10.1016/j.radcr.2021.11.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Duan H.Y., Guan Q., Guo Y.J., Liang N. Case report: Cardiac arrest during carotid body tumor resection indicating carotid sinus hypersensitivity. Front. Cardiovasc. Med. 2022;9:996644. doi: 10.3389/fcvm.2022.996644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Sakaran K.R.C., Tiew T., Kamil K., Khan H.A.H., Idris M.A., Safri L.S. Bilateral carotid body tumours: A case report from surgeon’s perspective. J. Surg. Case Rep. 2024;2024:rjae011. doi: 10.1093/jscr/rjae011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Cidral L.S.R., Penzo L.D., Merida K.B., Marques M., Andrade A.C., Aragão A.H., Ruschel L.G. Bilateral Carotid Body Paraganglioma: A Case Report and Review of Management Strategies. J. Neurol. Surg. Rep. 2025;86:e175–e179. doi: 10.1055/a-2654-2376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Cass N.D., Schopper M.A., Lubin J.A., Fishbein L., Gubbels S.P. The Changing Paradigm of Head and Neck Paragangliomas: What Every Otolaryngologist Needs to Know. Ann. Otol. Rhinol. Laryngol. 2020;129:1135–1143. doi: 10.1177/0003489420931540. [DOI] [PubMed] [Google Scholar]
  • 29.Palade D.O., Hainarosie R., Zamfir A., Vrinceanu D., Pertea M., Tusaliu M., Mocanu F., Voiosu C. Paragangliomas of the Head and Neck: A Review of the Latest Diagnostic and Treatment Methods. Medicina. 2024;60:914. doi: 10.3390/medicina60060914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Vimawala S.N., Graboyes A.Z., Bennett B., Bonanni M., Abbasi A., Oliphant T., Alonso-Basanta M., Rassekh C., Cohen D., Brant J.A., et al. Head and Neck Paragangliomas: Overview of Institutional Experience. Cancers. 2024;16:1523. doi: 10.3390/cancers16081523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Else T., Greenberg S., Fishbein L. Hereditary Paraganglioma-Pheochromocytoma Syndromes. GeneReviews®. [(accessed on 15 March 2026)];2023 Available online: https://www.ncbi.nlm.nih.gov/books/NBK1548/
  • 32.Neumann H.P., Pawlu C., Peczkowska M., Bausch B., McWhinney S.R., Muresan M., Buchta M., Franke G., Klisch J., Bley T.A., et al. Distinct Clinical Features of Paraganglioma Syndromes Associated With SDHB and SDHD Gene Mutations. JAMA. 2004;292:943–951. doi: 10.1001/jama.292.8.943. [DOI] [PubMed] [Google Scholar]
  • 33.Kantorovich V., King K.S., Pacak K. SDH-related Pheochromocytoma and paraganglioma. Best Pract. Res. Clin. Endocrinol. Metab. 2010;24:415. doi: 10.1016/j.beem.2010.04.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Bellamkonda N., Tooker E.L., Naumer A., Buchmann L.O., Kohlmann W., McCrary H.C., Patel N.S., Espahbodi M. Management of bilateral head and neck paragangliomas at a single-institution across four decades. Head Neck. 2025;47:386–393. doi: 10.1002/hed.27923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Gupta N., Strome S.E., Hatten K.M. Is routine genetic testing warranted in head and neck paragangliomas? Laryngoscope. 2019;129:1491–1493. doi: 10.1002/lary.27656. [DOI] [PubMed] [Google Scholar]
  • 36.Jansen J.C., Van Den Berg R., Kuiper A., Van Der Mey A.G.L., Zwinderman A.H., Cornelisse C.J. Estimation of Growth Rate in Patients with Head and Neck Paragangliomas Influences the Treatment Proposal. Cancer. 2000;88:2811–2816. doi: 10.1002/1097-0142(20000615)88:12<2811::aid-cncr21>3.3.co;2-z. [DOI] [PubMed] [Google Scholar]
  • 37.Sandow L., Thawani R., Kim M.S., Heinrich M.C. Paraganglioma of the Head and Neck: A Review. Endocr. Pract. 2023;29:141–147. doi: 10.1016/j.eprac.2022.10.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Fang F., Ding L., He Q., Liu M. Preoperative Management of Pheochromocytoma and Paraganglioma. Front. Endocrinol. 2020;11:586795. doi: 10.3389/fendo.2020.586795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Shamblin W.R., ReMine W.H., Sheps S.G., Harrison E.G. Carotid body tumor (chemodectoma). Clinicopathologic analysis of ninety cases. Am. J. Surg. 1971;122:732–739. doi: 10.1016/0002-9610(71)90436-3. [DOI] [PubMed] [Google Scholar]
  • 40.Richter S., Constantinescu G., Fancello G., Paties C.T., Mariani-Costantini R., Sanna M. Head and neck paragangliomas: Recent advances in translational and clinical research and guidelines for patient care. Best Pract. Res. Clin. Endocrinol. Metab. 2024;38:101951. doi: 10.1016/j.beem.2024.101951. [DOI] [PubMed] [Google Scholar]
  • 41.Magliulo G., Zardo F., Varacalli S., D’Amico R. Multiple paragangliomas of the head and neck. Otorrinolaringol. Ibero Am. 2003;30:31–38. [PubMed] [Google Scholar]
  • 42.Hamidi O., Young W.F., Jr., Gruber L., Smestad J., Yan Q., Ponce O.J., Prokop L., Murad M.H., Bancos I. Outcomes of patients with metastatic phaeochromocytoma and paraganglioma: A systematic review and meta-analysis. Clin. Endocrinol. 2017;87:440–450. doi: 10.1111/cen.13434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Del Guercio L., Narese D., Ferrara D., Butrico L., Padricelli A., Porcellini M. Carotid and Vagal Body Paragangliomas. Transl. Med. UniSa. 2013;6:11. [PMC free article] [PubMed] [Google Scholar]
  • 44.Bobadilla-Rosado L.O., Garcia-Alva R., Anaya-Ayala J.E., Peralta-Vazquez C., Hernandez-Sotelo K., Luna L., Cuen-Ojeda C., Hinojosa C.A. Surgical Management of Bilateral Carotid Body Tumors. Ann. Vasc. Surg. 2019;57:187–193. doi: 10.1016/j.avsg.2018.10.019. [DOI] [PubMed] [Google Scholar]
  • 45.Piazza C., Montenegro C., Rampinelli V. Bilateral carotid body tumor management: Tips, tricks, strategies, and problems. Curr. Opin. Otolaryngol. Head Neck Surg. 2025;33:123–130. doi: 10.1097/MOO.0000000000001035. [DOI] [PubMed] [Google Scholar]
  • 46.Neskey D.M., Hatoum G., Modh R., Civantos F., Telischi F.F., Angeli S., Weed D., Sargi Z. Outcomes after surgical resection of head and neck paragangliomas: A review of 61 patients. Skull Base. 2011;21:171–176. doi: 10.1055/s-0031-1275251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Suhail K., Kuldeep R., Ajaz W., Farzana F. Heart rhythm irregularities during laparoscopy: Description of a novel technique to manage severe intra-operative bradycardia—A case report. Int. J. Surg. Case Rep. 2023;105:107997. doi: 10.1016/j.ijscr.2023.107997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Bauer A.M., Smith R.B., Thorell W.E. Implications of carotid sinus hypersensitivity following preoperative embolization of a carotid body tumor. An indication for prophylactic intraoperative cardiac pacing. JAMA Otolaryngol. Head. Neck Surg. 2014;140:459–463. doi: 10.1001/jamaoto.2014.144. [DOI] [PubMed] [Google Scholar]
  • 49.Alanezi T., Alomran F., Koussayer S., Abdulrahim O., Dahman M., Alsuhaibani E., Alokaili R., Al-Omran M. Preoperative radiological features in predicting complications of carotid body tumor resection. J. Vasc. Surg. 2025;81:665–671.e2. doi: 10.1016/j.jvs.2024.11.008. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All data generated or analyzed during this study are included in this published article. Additional details are available from the corresponding author upon reasonable request.


Articles from Journal of Clinical Medicine are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES